A novel prognostic marker associated with superior patient survival in soft tissue sarcoma
Checkpoint inhibitors are slowly being introduced in the care of specific sarcoma subtypes such as undifferentiated pleomorphic sarcoma. The present study explores the hypothesis that CD11c+ APCs in direct cell–cell contact with CD8+ T cells at the tumor site are associated with an active anti-tumor immune microenvironment and favorable prognosis. In this MEDtalk Monika Ehnma, Department of Oncology-Pathology, Karolinska Institute, present the result of the study.
Get access to the article
If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.